Lallemand, world leader in the development, production and sale of yeasts, bacteria and derived ingredients, associated with UMR MEDIS (Digestive environment and health microbiology dependent on Inra and university) asked Dendris to develop a biochip for studying the intestinal microbiota in animals.

This program will be based on the work carried out by LALLEMAND / UMR MEDIS on the identification of biomarkers characteristic of ruminal fibrolytic activity. The aim is to verify the application of Dendris technology in this context.